Theradiag TRACKER – leaders in Therapeutic Drug Monitoring

Theradiag is the market leader in Therapeutic Drug Monitoring (TDM) with assays validated and supported by the pharmaceutical industry.

Why use Theradiag TRACKER for Therapeutic Drug Monitoring

Pioneer and expert in TDM of biotherapies
Unique TDM menu with 12 different kits available for drug and anti-drug antibodies
Full coverage of biotherapies used in IBD, but also other chronic inflammatory diseases and oncology
Accurate quantitative measurement of drug and anti-drug antibodies
Easy-to-use with standardized protocols from sample collection to result interpretation
Clinically validated with measurement ranges tailored to induction and maintenance treatment phases
Flexible kit formats:
- Easy-to-implement ELISA kits validated on automated platforms (DS2, DSX, Evolis, etc.)
- Fully automated CLIA kits on random-access i-Track¹⁰ analyser
Validated on biosimilars
Validated and supported by the pharmaceutical industry
Validated in accordance with the WHO international standards
TRACKER kits included in a large number of studies and publications

Therapeutic Drug monitoring helps physicians to make rational therapeutic decisions during the course of the disease and to support the proper use of drugs
Proactive and reactive TDM during treatment induction and maintenance to maximize the clinical benefits of biotherapies while minimizing side effects
TDM approach leads to major cost savings in healthcare settings compared to a clinically based approach
Update on the latest data available for therapeutic windows for all molecules used in IBD
TRACKER kits included in a large number of studies and publications